Titles and Roles
- Professor, Department of Dermatology
- Emory University School of Medicine
- Investigational Labs
- Research Program
- Discovery and Developmental Therapeutics
Board certified in dermatology, Jack Arbiser, MD, PhD, started practicing at Emory Healthcare in 1998. His clinical specialties include lichen planus, melanoma and skin cancer.
Dr. Arbiser is a core member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute of Emory University. He also holds memberships in the American Academy of Dermatology and the Society of Investigative Dermatology.
Dr. Arbiser joined the Dermatology Department at Emory after completing his PhD and medical school training, internship, and residency at Harvard, and then a three-year Howard Hughes Fellowship at Children’s Hospital of Boston in Boston, Massachusetts.
Dr. Arbiser has received the Healthgrade Honor Roll award.
Dr. Arbiser's research focuses on the regulation of angiogenesis and tumorigenesis by signal transduction pathways. Our laboratory has chosen three model systems to study these relationships. The first area is the common vascular birthmarks of children and their malignant counterparts, angiosarcomas. The second application of these studies are benign neoplasms which develop in the autosomal dominant syndrome tuberous sclerosis (TS). The third application of these studies is in the pathogenesis of malignant melanoma. Dr Arbiser has developed the hypothesis that oncogenes disrupt the balance between angiogenesis stimulators and inhibitors.